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Lincomycin, chlortetracycline, and amoxicillin are commonly used antimicrobials for growth
promotion and infectious disease prophylaxis in swine production. In this study, we
investigated the shifts and resistance development among intestinal microbiota in pregnant
sows before and after lincomycin, chlortetracycline, and amoxicillin treatment by using phy-
logenetic analysis, bacterial enumeration, and PCR.After the antimicrobial treatment, shifts
in microbial community, an increased proportion of resistant bacteria, and genes related
to antimicrobial resistance as compared to the day before antimicrobial administration (day
0) were observed. Importantly, a positive correlation between antimicrobial resistance
gene expression in different categories, especially those encoding aminoglycoside and
β-lactamase and antimicrobial resistance, was observed. These ﬁndings demonstrate
an important role of antimicrobial usage in animals in the development of antimicrobial
resistance, and support the notion that prudent use of antimicrobials in swine is needed
to reduce the risk of the emergence of multi-drug resistant zoonotic pathogens.
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INTRODUCTION
During animal production, antimicrobials are routinely used at
subtherapeutic levels for growth promotion and infectious dis-
ease prevention, as well as at therapeutic levels for treatment of
infections (Jindal et al., 2006). Various antimicrobials have made
signiﬁcant contributions to lowered incidence of diseases, reduc-
ing morbidity and mortality, and for production of abundant
quantities of nutritious, high-quality, low-cost food for human
consumption (Oliver et al., 2011). For the year ending December
2007, global sales of animal health products (including antimicro-
bials) totaled $17.9 billion, which increased tremendously from
$8.65 billion in 1992 (Page and Gautier, 2012).
Although there are signiﬁcant beneﬁts of antimicrobials in
agriculture, liberal antimicrobial use has raised lasting concerns
about antimicrobial residues in animal food products, and a rapid
and widespread emergence of resistance to multiple antimicro-
bials among both animal and human pathogens (Aarestrup and
Wegener, 1999). Furthermore, the antimicrobial residues and
antimicrobial-resistant bacteria animal feces are potential “time
bombs,” because they could be excreted into the environment and
threaten public health for a long time (Mathew et al., 1998). To
make things worse, antimicrobial combinations are used most
frequently to provide a broad-spectrum of antimicrobial activ-
ity, or in an attempt to promote better growth performance in
food-producing animals. Althoughnegative effects – such as devel-
opment of changes in commensal microorganisms, as well as the
emergence of an enormous diversity of antimicrobial resistance
genes and multidrug-resistant strains in animals – have been
ignored for a long time, they have attracted more and greater
attention in recent years (Hao et al., 2014).
Using high-throughput metagenomics, Looft et al. (2012)
revealed that the bacterial phylotypes shifted after antimicrobial
treatment, and the microbial functional genes relating to energy
production and conversion were increased in antimicrobial-fed
pigs. The ﬁndings shed light on the fact that the addition of
antimicrobials to animal feed introduces a selective pressure
that may lead to lasting changes among commensal livestock
microorganisms. It has also been demonstrated that the use
of antimicrobials may promote the development of antimicro-
bial resistance among bacteria in animals (Singer et al., 2003).
Usually, there is a positive correlation between administration
of antimicrobials and fecal counts of corresponding resistant
bacteria. For instance, administration of ﬂuoroquinolone could
promote the emergence of quinolone-resistant Enterobacteria
in the fecal ﬂora of pigs (Nguyen et al., 2012). In addition,
use of a single antimicrobial may induce cross-resistance to
other antimicrobials that were not administrated. Receiving a
diet containing chlortetracycline, sulfamethazine, and penicillin
was associated with a rise of aminoglycoside resistance in pigs
(Looft et al., 2012). In fact, horizontal gene transfer is largely
the cause of the multi-drug resistance phenotype in intestinal
bacteria. The mobile genetic element harboring antimicrobial-
resistance genes (ARGs) can transfer among different gastroin-
testinal bacteria, which could be accelerated with the selective
pressure of antimicrobials in vivo (van Essen-Zandbergen et al.,
2009).
There have been various strategies for investigating live-
stock microbiota and fecal ARGs. Valuable information has
been obtained by culture-based approaches to investigate narrow
groups of bacteria or genes isolated from animal feces, such as
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cephalosporin resistance in cattle isolates (Madec et al., 2008).
Recently, a culture-independent method that utilizes extracted
DNA from all microorganisms present in fecal samples has been
widely used. This technique provides a global view of the bacte-
rial community, and assists in predicting ecosystem functioning
and further understanding of bacterial evolution (Roesch et al.,
2009; Looft et al., 2012). There is a paucity of data with regard to
the effects of subtherapeutic doses of antimicrobials on shifts and
antimicrobial resistance in intestinal microbiota, as well as levels
of various ARGs.
In the present study, we investigated phylogenetic clustering
of the intestinal microbiota, bacterial communities resistant to
antimicrobials, and levels of ARG expression before and after a
single administration of subtherapeutic doses of antimicrobials to
swine.
MATERIALS AND METHODS
SWINE, TREATMENT, AND SAMPLING
A pen (24 pregnant sows) from a typical intensive swine pro-
duction farm (2400 sows) in Guangdong Province, China, was
selected for the study. After artiﬁcial insemination, 24 sows were
fed the same diet without antimicrobials for at least 90 days. This
withdrawal period minimized the effects of drug residues on their
gastrointestinal microbiota (Arikan et al., 2006). In order to pre-
vent postpartum diseases, farrowing sows were given the above
diet containing lincomycin hydrochloride (500g/ton), chlortetra-
cycline (100g/ton), and amoxicillin (500g/ton) before delivery.
Fresh fecal samples were collected from sows at 0 days before
treatment (deﬁned as A) as the baseline (single administration of
subtherapeutic doses of the antimicrobials) and 3, 6, and 12 days
after treatment (B, C, and D). At each point, nine fecal samples
were randomly collected from 24 sows, and were then pooled to
form a single composite sample. The study protocol was reviewed
and approved by the South China Agriculture University animal
ethics committee. The owners of the sows from which fecal sam-
ples were taken gave permission for their animals to be used in this
study.
DNA EXTRACTIONS
Total DNA from fecal samples was extracted as previously
described Looft et al. (2012). DNA samples were quantiﬁed via
BioPhotometer plus (Eppendorf, Shanghai, China) and gel elec-
trophoresis. Extracted DNA samples had an A260/280 ratio of
≥1.6, and an A260/230 ratio of ≥2.0.
AMPLIFICATION AND 454 SEQUENCING OF THE 16S rRNA GENE
The V3-V5 regions of the bacterial 16S rRNA gene
were ampliﬁed with conserved primers: 357F (V3 primer)
5′-CCTACGGGAGGCAGCAG-3′ and 926R (V5 primer) 5′-CCG-
TCAATTCMTTTRAGT-3′ (Methe et al., 2012). Ampliﬁcation
primers were designed with FLX Titanium adapters (A adapter
sequence: 5′-CCATCTCATCCCTGCGTGTCTCCGACTCAG-3′;
B adapter sequence: 5′-CCTATCCCCTGTGTGCCTTGGCAGTC-
TCAG-3′), and a sample barcode sequence where applicable. For-
ward primers contained the B adapter, and the reverse primers
contained theA adapter. PCR products were then sequenced using
the Roche-454 FLX Titanium platform according to the “HMP
16S Protocol” (www.hmpdacc.org/doc/HMP_MDG_454_16S_
Protocol.pdf), and Ward et al. (2012). After adoption of the 16S
rRNA protocol, including removal of multiple sources of potential
artifacts or bias generated by 16S rRNA sequencing using pyrose-
quencing (Huse et al., 2007), phylogenetic analysis and taxonomic
assignments of the V3-V5 regions within the 16S rRNA gene were
performed using the mothur and QIIME (Schloss et al., 2009;
Caporaso et al., 2010).
BACTERIAL ENUMERATION
Six commonly used veterinary antimicrobials (ciproﬂoxacin,
tetracycline, erythromycin, clindamycin, gentamycin, and ampi-
cillin) were selected to estimate the relative abundance of
antimicrobial-resistant bacteria in fecal samples. Bacterial were
enumerated using a method described by (Yashiro and McManus,
2012); 3 g of the composite samples were blended in 50 ml sterile
PBS. After suspension, the sample was serially diluted and then
plated onto tryptic soy agar (TSA), as well as TSA amended with
ciproﬂoxacin (4 μg/ml), tetracycline (16 μg/ml), erythromycin
(8 μg/ml), clindamycin (4 μg/ml), gentamicin (16 μg/ml), and
ampicillin (32 μg/ml) to select for each antimicrobial-resistant
bacteria. After incubation for 7 days at room temperature (Yashiro
and McManus, 2012), colony-forming units (cfu) were counted,
and the proportion resistant to antimicrobials was calculated. The
proportion of bacterial communities resistant to each antimicro-
bial of sample A was treated as the control. Bacterial enumeration
assays were performed on three separate experiments, with three
replications per assay used for each experiment.
DETECTION AND RELATIVE QUANTIFICATION OF ARGs
Polymerase chain reaction (PCR) detection assays were used to
screen six ARG types: plasmid-mediated quinolone resistance
(PMQR), tetracycline, macrolide, lincomycin, aminoglycoside
inactivating enzymes, and β-lactamase in the fecal samples. All
primers used in this study are shown in Table S1. To ensure
reproducibility, three replicate assays for each sample were per-
formed in parallel with positive and negative controls in each
run. ARGs detected by PCR and 16S rRNA genes were further
quantiﬁed by qPCR using the SybrGreen approach. The qPCR
was performed with SYBR® Premix Ex TaqTM (TaKaRa Bio) in a
thermal cycler (iQ5; Bio-Rad, Hercules, CA, USA) according to
the manufacturer’s instructions. The conditions were as follows:
denaturing at 94◦C for 5 min, followed by 35 cycles at 94◦C for
1 min, at 60◦C for 1 min, and at 72◦C for 1 min, with a ﬁnal
extension at 72◦C for 5 min; the melt curve was read from 60 to
95◦C every 1◦C at the end of the assay. A Eubacterial 16S rRNA
gene was also quantiﬁed according to the SybrGreen approach
(Bach et al., 2002), so that ARGs could be normalized to the
total bacterial community. This step provided a means to cor-
rect for potential variations in extraction efﬁciencies and compare
ARGs proportionally between samples of different overall pop-
ulation sizes. All DNA samples were diluted to 2 ng/μL in TE
buffer prior to qPCR ampliﬁcation. Matrix effects associated with
extraction of DNA from fecal samples were corrected as previously
described (Pei et al., 2006). The ARG copy numbers normalized
to ambient 16S rRNA gene copies of sample A were treated as
the control. All experiments were performed in triplicate, and
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standard error of the measurements was determined from these
parallel data.
STATISTICAL ANALYSIS
Data analysis was conducted using SPSS version 16.0. A two-
tailed Student’s t-test was calculated on the mean percentage
of antimicrobial resistance between the samples to determine
the impact of single administration of subtherapeutic doses of
antimicrobials on bacterial populations. A p-value of <0.05 was
considered statistically signiﬁcant. Changes in ARG copy num-
bers were considered to be signiﬁcant when the corresponding
ratios were ≥2.5 or ≤0.4. A two-tailed Pearson’s bivariate cor-
relation analysis was used to compare relative abundances of
ARGs.
RESULTS
SHIFTS IN MICROBIAL COMMUNITY WITH ANTIMICROBIAL
TREATMENT
We collected 79194 sequences of the V3–V5 regions of bacte-
rial 16S rRNA genes from a total of ﬁve fecal samples. The
majority of classiﬁable sequences (95.6 to 98.6%) belonged to
the Firmicutes, Proteobacteria, and Bacteroidetes phyla. Speciﬁc
changes in the microbial community associated with antimi-
crobial treatment included a decrease from 54.6 to 16.8%
(p < 0.005) in the abundance of Proteobacteria phyla. In addi-
tion, the increase in Firmicutes abundance with antimicrobial
treatment was particularly striking, with 42.1% of the pop-
ulation in sample A to 79% of the population in sample D
(p< 0.05; Figure 1A). Members of the Bacteroidetes, Spirochaetes,
Euryarchaeota, and Actinobacteria phyla increased by 2.5-, 5-,
1.1-, and 2-fold, respectively, (p < 0.05) at the third or sixth
day after antimicrobial treatment (Sample B or C), and then
returned to normal levels 12 days after treatment. Genus-level
composition of common pathogens and opportunistic pathogens
indicated that after antimicrobial treatment Escherichia/Shigella
decreased by 40% (p < 0.05). Interestingly, Streptococcus pop-
ulations were the major difference before and after treatment:
11–110-fold less abundance in samples B, C, and D than sam-
ple A (p < 0.05; Figure 1B). Treponema, Enterococcus, and
Staphylococcus populations were increased by 6-, 14-, 2-fold,
respectively, (p < 0.05) within a week but returned to baseline
6 days later.
SHIFTS IN THE NUMBER OF RESISTANT BACTERIA WITH
ANTIMICROBIAL TREATMENT
The proportion of bacteria communities resistant to tetracy-
cline, erythromycin, and clindamycin were increased after treat-
ment. Only clindamycin-resistant bacterial communities were
increased signiﬁcantly (p < 0.01; Figure 2). Moreover, the pro-
portion of bacterial communities resistant to gentamycin and
ampicillin still shows an upward trend (from 20.4 and 29.6
to 87.1% and 73.8%, respectively, – p < 0.001) 12 days after
treatment (Figure 2). An increase in the proportion of bacterial
communities that was resistant to ciproﬂoxacin was observed
after treatment (from 10.4 to 18.8 to 21.3% – p < 0.05),
and it was then recovered in sample D collected on day
12 (9.8%).
SHIFTS IN ARGs ABUNDANCE WITH ANTIMICROBIAL TREATMENT
Among the 53 ARGs investigated, PMQR ARGs: aac(6′)-Ib-
cr and qepA, tetracycline ARGs: tet(L), tet(Q) ,and tet(W),
macrolide ARGs: ermA, ermB, mefA, and ereA, lincomycin ARGs:
ermA, ermB, lnuA, and lnuF, aminoglycoside inactivating enzyme
encoding ARGs: aac(3′)-IIc, aadA1, aadB, aph(3′)-II, aph(3′)-IV,
aph(4′)-Ia, and armA, and β-lactamase-encoding ARGs: blaTEM,
blaCTX−M−9G and blaOXA were detected in all samples before and
after treatment. In general, the qPCR results revealed 4 ARG types
with signiﬁcantly greater abundance (by 10-, 50-, 1000-, and 40-
fold, respectively, p < 0.01) in samples collected after treatment
than before treatment: aminoglycoside ARGs, lincomycin ARGs,
macrolide ARGs, and tetracycline ARGs (Figure 3; Table S2). The
relative abundance of β-lactam ARGs increased at ﬁrst, but then
decreased after treatment.
CORRELATION ANALYSIS
Signiﬁcant, positive correlations among different resistance genes
in the same category of ARGs were observed in the relative abun-
dances of 6 ARG types (Table S3). Furthermore, there was a
signiﬁcant correlation between various types of ARGs, such as the
sum of macrolide ARGs, sum of aminoglycoside ARGs (r = 0.945,
p = 0.015), and sum of β-lactam ARGs (r = 0.961, p = 0.009).
DISCUSSION
We assessed the shifts in fecal microbiota in sows that received
antimicrobial treatment. The ratio of Bacteroidetes to Firmicutes
decreased signiﬁcantly 12 days after antimicrobial treatment. Pre-
vious studies reported that obese mice had a lower ratio of
Bacteroidetes to Firmicutes in their feces compared with lean
mice. Presumably because of this shift, obese mice have an
improved energy-harvesting capacity (Turnbaugh et al., 2006).
Perhaps growth-promoting beneﬁts obtained from feeding swine
antimicrobials, especially chlortetracycline, as part of their diets
are due to this shift. Additionally, Escherichia coli is a com-
mon porcine enteric pathogen, causing diarrhea in new-born
and weaned pigs, and edema in pigs after weaning (Frydendahl
et al., 2003). Antimicrobials could decrease the duration of fecal
shedding of E. coli by swine (Cornick, 2010), and therefore the
decrease in E. coli following antimicrobial treatment could help
reduce the risk of transmission from sows to piglets, thus reducing
the morbidity and mortality of piglets. In this study, a decrease
(40%, p < 0.05) in Escherichia/Shigella was found after treat-
ment with antimicrobials. The same beneﬁcial decline was also
found in Streptococcus in our study, among which Streptococcus
suis is mainly associated with bronchopneumonia, meningitis,
and septicemia (Higgins et al., 1990). However, other pathogens
or opportunistic pathogens such as Staphylococcus aureus, Tre-
ponema hyodysenteriae, and Enterococcus faecalis increased several
days after antimicrobial treatment. These increases would be an
undesirable collateral effect of in-feed antimicrobials, and are a
threat to the health of sows and piglets (Larson et al., 1985). More-
over, these potential pathogens may eventually threaten human
health through the food chain.
In this study, antimicrobial treatment caused a detectable
increase in the proportion of antimicrobial-resistant bacteria in
the community and the abundance of resistance genes. Many of
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FIGURE 1 | Shifts in fecal bacterial community memberships with
antibiotic treatment. (A) Phylum-level composition of fecal microbial
communities. Data were pooled for fecal samples isolated from the
day 0 before treatment (A) and the day 3, 6, 12 after treatment
(B–D) and are shown as percentage of abundance. (B) Genus-level
composition of common pathogens and opportunistic pathogens,
shown as the total number of sequences (normalized to 50000 total
reads).
these resistance genes were likely enriched because of direct inter-
action with the antimicrobials such as tetracycline, clindamycin,
and ampicillin. Tetracycline is used frequently for the treatment
and/or prevention of bacterial diseases and for growth promotion
within the swine industry (Agriculture, 1996, 2000). Furthermore,
a low, short-term dose of in-feed tetracycline could promote an
increase in tetracycline efﬂux pump expression (Looft et al., 2012).
Therefore, the tetracycline resistance rate could remain at a high
level before treatment and increase from 69.8 to 75.4 to 85.4%
to 97.1% after treatment in this study. Viable but non-culturable
(VBNC) bacteria were not considered in the bacterial enumera-
tion assay under the culture condition described in the method,
because they accounted for only a few of each zoonotic pathogen
(Pinto et al., 2011; Trevors, 2011).
An increase in the abundance of the sum of tetracycline ARGs
was detected after in-feed antimicrobial treatment. A similar sit-
uation also appears with clindamycin. In this study, a high level
of erm(A) and erm(B) genes, which could confer resistance to
both clindamycin and macrolide, was detected before and after
treatment. Additionally, decreased cell membrane permeability
and/or multi-drug efﬂux pumps could make macrolides ineffec-
tive against gram-negative bacteria. These two factors may have
contributed to the high macrolide-resistance rates in this study
(Levy, 2002; Rodrigues et al., 2009).
It is noteworthy that the aminoglycoside ARGs increased in
abundance with treatment, although they do not confer resistance
to the antimicrobials therein. Furthermore, signiﬁcant correla-
tions among different category ARGs, such as blaOXA and aadA1,
blaOXA, and aac(3′)-IIc were observed. This might be explained
by the previous ﬁndings that blaOXA−21 and aadA1 could both
be embedded within a class 1 integron in a gene cassette array,
and blaOXA and aac(3′)-IIc genes could be co-located on the
same large conjugative IncFII(K) plasmids (Dolejska et al., 2012;
Yamamoto et al., 2013). Additionally, tet and aadA1, which could
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FIGURE 2 | Cultivation based estimation of relative abundance of
ciprofloxacin-resistant (cipR), tetracycline-resistant (tetR),
erythromycin-resistant (eryR), clindamycin-resistant (linR),
gentamycin-resistant (genR), and ampicillin-resistant (ampR) bacteria
in fecal samples isolated from day 0 before treatment (A) and day 3, 6,
12 after treatment (B–D). Asterisks indicate statistically signiﬁcant
(p < 0.05) differences between day 0 before treatment and day 3, 6, 12
after treatment.
co-locate in the same strains, also presented signiﬁcant cor-
relations (Radhouani et al., 2013). Overall, due to the indirect
mechanism of selection mentioned above, the observation of an
increased abundance in aminoglycoside ARGs after treatment in
our study can be partially explained. We also observed the correla-
tion between different categoryARGs, such asmefA and armA, and
ereA and armA. Although reports of these resistance genes located
in the same bacteria or mobile elements are lacking, we remain
concerned about these genes which could be indirectly induced by
antimicrobials, and might cause the emergence of MDR bacteria.
More so, the ARGs remain at a high level 12 days after treatment,
and could be continually discharged into the environment, thus
may potentially threaten public health.
In conclusion, these results indicate that even a low, short-term
dose of antimicrobials can increase the proportion of resistant-
bacterial communities, abundance of ARGs, including resistance
to antimicrobials not administered, and the abundance of poten-
tial human pathogens, such as S. aureus. Additionally, the positive
correlation between different category ARGs showed that the
emergence of MDR bacteria might be due to the collateral effects
of antimicrobial use. The data from this study further warn
that the prudent use of antimicrobials in swine is necessary to
reduce the risks of emergence of multi-drug resistance zoonotic
pathogens.
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FIGURE 3 | Relative abundances of aminoglycoside ARGs (A), β-lactam
ARGs (B), lincomycin ARGs, (C) and tetracycline ARGs (D) in fecal
samples isolated before and after treatment, normalized to ambient
16S rRNA gene copies.
www.frontiersin.org November 2014 | Volume 5 | Article 580 | 5
Sun et al. Antimicrobial resistance in intestinal microbiota
SUPPLEMENTARY MATERIAL




Aarestrup, F. M., and Wegener, H. C. (1999). The effects of antibiotic usage in
food animals on the development of antimicrobial resistance of importance for
humans in Campylobacter and Escherichia coli. Microbes Infect. 1, 639–644.
Agriculture U. S. D. O. (1996). Swine ’95. II. Reference of 1995 U.S.grower/ﬁnisher
health and management practices. USDA APHIS VS CEAH. National Animal
Health Monitoring System, Fort Collins, Colo.
Agriculture U. S. D. O. (2000). III. Health management and biosecurity in U.S.
feedlots 1999. No. N336.1200. USDA APHIS VS CEAH. National Animal Health
Monitoring System, Fort Collins, Colo.
Arikan,O.A., Sikora, L. J.,Mulbry,W., Khan, S. U., Rice, C., and Foster, G. D. (2006).
The fate and effect of oxytetracycline during the anaerobic digestion of manure
from therapeutically treated calves. Process Biochem. 41, 1637–1643.
Bach, H. J., Tomanova, J., Schloter, M., and Munch, J. C. (2002). Enumeration
of total bacteria and bacteria with genes for proteolytic activity in pure cultures
and in environmental samples by quantitative PCR mediated ampliﬁcation. J.
Microbiol. Methods 49, 235–245.
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello,
E. K., et al. (2010). QIIME allows analysis of high-throughput community
sequencing data. Nat. Methods 7, 335–336.
Cornick, N. A. (2010). Tylosin and chlorotetracycline decrease the duration of fecal
shedding of E-coli O157:H7 by swine. Vet. Microbiol. 143, 417–419.
Dolejska, M., Brhelova, E., Dobiasova, H., Krivdova, J., Jurankova, J., Sevcikova, A.,
et al. (2012). Dissemination of IncFII(K)-type plasmids in multiresistant CTX-
M-15-producing Enterobacteriaceae isolates from children in hospital paediatric
oncology wards. Int. J. Antimicrob. Agents 40, 510–515.
Frydendahl, K., Jensen, T. K., Andersen, J. S., Fredholm, M., and Evans, G. (2003).
Association between the porcine Escherichia coli F18 receptor genotype and phe-
notype and susceptibility to colonisation and postweaning diarrhoea caused by
E-coli O138:F18. Vet. Microbiol. 93, 39–51.
Hao, H., Cheng, G., Iqbal, Z., Ai, X., Hussain, H. I., Huang, L., et al. (2014). Beneﬁts
and risks of antimicrobial use in food-producing animals. Front. Microbiol. 5:288.
doi: 10.3389/fmicb.2014.00288
Higgins, R., Gottschalk, M., Mittal, K. R., and Beaudoin, M. (1990). Streptococcus
suis infection in swine. A sixteen month study. Can. J. Vet. Res. 54, 170–173.
Huse, S. M., Huber, J. A., Morrison, H. G., Sogin, M. L., and Mark Welch, D. (2007).
Accuracy and quality of massively parallel DNA pyrosequencing. Genome Biol.
8:R143.
Jindal, A., Kocherginskaya, S., Mehboob, A., Robert, M., Mackie, R. I., Raskin, L.,
et al. (2006). Antimicrobial use and resistance in swine waste treatment systems.
Appl. Environ. Microbiol. 72, 7813–7820.
Larson, C. T., Gross, W. B., and Davis, J. W. (1985). Social stress and resistance of
chicken and swine to Staphylococcus aureus challenge infections. Can. J. Comp.
Med. 49, 208–210.
Levy, S. B. (2002). Active efﬂux, a common mechanism for biocide and antibiotic
resistance. J. Appl. Microbiol. 92, 65S–71S.
Looft, T., Johnson, T.A., Allen, H. K., Bayles, D. O., Alt, D. P., Stedtfeld, R. D., et al.
(2012). In-feed antibiotic effects on the swine intestinal microbiome. Proc. Natl.
Acad. Sci. U.S.A. 109, 1691–1696.
Madec, J. Y., Lazizzera, C., Chatre, P., Meunier, D., Martin, S., Lepage, G.,
et al. (2008). Prevalence of fecal carriage of acquired expanded-spectrum
cephalosporin resistance in Enterobacteriaceae strains from cattle in France. J.
Clin. Microbiol. 46, 1566–1567.
Mathew, A. G., Upchurch, W. G., and Chattin, S. E. (1998). Incidence of antibiotic
resistance in fecal Escherichia coli isolated from commercial swine farms. J. Anim.
Sci. 76, 429–434.
Methe, B. A., Nelson, K. E., Pop, M., Creasy, H. H., Giglio, M. G., Huttenhower, C.,
et al. (2012). A framework for humanmicrobiome research. Nature 486, 215–221.
Nguyen, T. T., Chachaty, E., Huy, C., Cambier, C., De Gunzburg, J., Mentre, F.,
et al. (2012). Correlation between fecal concentrations of ciproﬂoxacin and fecal
counts of resistant Enterobacteriaceae inpiglets treatedwith ciproﬂoxacin: toward
new means to control the spread of resistance? Antimicrob Agents Chemother 56,
4973–4975.
Oliver, S. P., Murinda, S. E., and Jayarao, B. M. (2011). Impact of antibiotic use in
adult dairy cows on antimicrobial resistance of veterinary and human pathogens:
a comprehensive review. Foodborne Pathog. Dis. 8, 337–355.
Page, S. W., and Gautier, P. (2012). Use of antimicrobial agents in Livestock. Rev.
Sci. Tech. 31, 145–188.
Pei, R. T., Kim, S. C., Carlson, K. H., and Pruden, A. (2006). Effect of river land-
scape on the sediment concentrations of antibiotics and corresponding antibiotic
resistance genes (ARG). Water Res. 40, 2427–2435.
Pinto, D., Almeida, V., Almeida Santos, M., and Chambel, L. (2011). Resuscitation
of Escherichia coli VBNC cells depends on a variety of environmental or chemical
stimuli. J. Appl. Microbiol. 110, 1601–1611.
Radhouani, H., Igrejas, G., Goncalves, A., Estepa, V., Sargo, R., Torres, C.,
et al. (2013). Molecular characterization of extended-spectrum-beta-lactamase-
producing Escherichia coli isolates from red foxes in Portugal. Arch. Microbiol.
195, 141–144.
Rodrigues, L., Sampaio, D., Couto, I., Machado, D., Kern, W. V., Amaral, L., et al.
(2009). The role of efﬂux pumps inmacrolide resistance inMycobacterium avium
complex. Int. J. Antimicrob. Agents 34, 529–533.
Roesch, L. F. W., Lorca, G. L., Casella, G., Giongo, A., Naranjo, A., Pionzio, A. M.,
et al. (2009). Culture-independent identiﬁcation of gut bacteria correlated with
the onset of diabetes in a rat model. ISME J. 3, 536–548.
Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R., Hartmann, M., Hollister,
E. B., et al. (2009). Introducing mothur: open-source, platform-independent,
community-supported software for describing and comparing microbial com-
munities. Appl. Environ. Microbiol. 75, 7537–7541.
Singer, R. S., Finch, R., Wegener, H. C., Bywater, R., Walters, J., and Lipsitch, M.
(2003). Antibiotic resistance – the interplay between antibiotic use in animals and
human beings. Lancet Infect. Dis. 3, 47–51.
Trevors, J. T. (2011). Viable but non-culturable (VBNC) bacteria: Gene expression
in planktonic and bioﬁlm cells. J. Microbiol. Methods 86, 266–273.
Turnbaugh, P. J., Ley, R. E.,Mahowald,M.A.,Magrini,V.,Mardis, E. R., andGordon,
J. I. (2006). An obesity-associated gut microbiome with increased capacity for
energy harvest. Nature 444, 1027–1031.
van Essen-Zandbergen, A., Smith, H., Veldman, K., and Mevius, D. (2009). In vivo
transfer of an incFIB plasmid harbouring a class 1 integron with gene cassettes
dfrA1-aadA1. Vet. Microbiol. 137, 402–407.
Ward, D. V., Gevers, D., Giannoukos, G., Earl, A. M., Methé, B. A., Sodergren,
E., et al. (2012). Evaluation of 16S rDNA-based community proﬁling for human
microbiome research. PLoS ONE 7:e39315. doi: 10.1371/journal.pone.0039315
Yamamoto, M., Nagao, M., Matsumura, Y., Hotta, G., Matsushima, A., Ito, Y., et al.
(2013). Regional dissemination of Acinetobacter species harbouring metallo-
beta-lactamase genes in Japan. Clin. Microbiol. Infect. 19, 729–736.
Yashiro, E., and McManus, P. S. (2012). Effect of Streptomycin treatment on bac-
terial community structure in the apple phyllosphere. PLoS ONE 7:e37131. doi:
10.1371/journal.pone.0037131
Conflict of Interest Statement:The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 06 August 2014; accepted: 14 October 2014; published online: 04 November
2014.
Citation: Sun J, Li L, Liu B, Xia J, Liao X and Liu Y (2014) Development of amino-
glycoside and β-lactamase resistance among intestinal microbiota of swine treated
with lincomycin, chlortetracycline, and amoxicillin. Front. Microbiol. 5:580. doi:
10.3389/fmicb.2014.00580
This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section
of the journal Frontiers in Microbiology.
Copyright © 2014 Sun, Li, Liu, Xia, Liao and Liu. This is an open-access article
distributed under the terms of the Creative Commons Attribution License (CC BY).
The use, distribution or reproduction in other forums is permitted, provided the original
author(s) or licensor are credited and that the original publication in this journal is cited,
in accordance with accepted academic practice. No use, distribution or reproduction is
permitted which does not comply with these terms.
Frontiers in Microbiology | Antimicrobials, Resistance and Chemotherapy November 2014 | Volume 5 | Article 580 | 6
